Global Cardio Oncology Registry

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• New cardio-oncology consultation for breast cancer patients, or

• New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or

• New cardio-oncology consultation for acute or chronic leukemia patients, or

• New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or

• New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation.

• All patients have to be 18 years old or older

Locations
United States
Florida
Cleveland Clinic Florida
RECRUITING
Weston
Contact Information
Primary
Diego Sadler, MD FACC
sadlerd@ccf.org
5613898833
Backup
Rohit Moudgil, MD PhD
moudgir@ccf.org
216-445-1932
Time Frame
Start Date: 2022-07-01
Estimated Completion Date: 2027-07-01
Participants
Target number of participants: 5000
Treatments
Breast cancer
Patients with breast cancer who present for initial cardio-oncology consultation. Clinical follow up for 18 months.
Hematological malignancies
Patients with lymphomas, leukemias, multiple myeloma, and AL amyloidosis who present for initial cardio-oncology consultation. Clinical follow up for 18 months.
Immune check point inhibitors
Patients with any type of cancer treated with immune check point inhibitors who present for initial cardio-oncology consultation. Clinical follow for 18 months
Sponsors
Leads: The Cleveland Clinic

This content was sourced from clinicaltrials.gov